Raxibacumab: Treatment of anthrax infection

Drugs of the Future

Volumn 35, Issue 3, 2010, Pages 179-182

  Adusumilli, S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABTHRAX; ANTHRAX TOXIN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CIPROFLOXACIN; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; RAXIBACUMAB; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANTHRAX; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGEN BINDING; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BACILLUS ANTHRACIS; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IC 50; IMMUNOTHERAPY; INFECTION PREVENTION; MAXIMUM PLASMA CONCENTRATION; NAUSEA; NONHUMAN; SINGLE DRUG DOSE;

EID: 84952982504     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2010.035.03.1487082     Document Type: Article

References (27)

1. Subramanian, G.M., Cronin, P.W., Poley, G. et al. A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers. Clin Infect Dis 2005, 41(1): 12-20. (Pubitemid 40863738)
2. Kolsto, A.B., Tourasse, N.J., Okstad, O.A. What sets Bacillus anthracis apart from other Bacillus species? Annu Rev Microbiol 2009, 63: 451-76.
3. Mock, M., Fouet, A. Anthrax. Annu Rev Microbiol 2001, 55: 647-71.
4. Holty, J.E., Bravata, D.M., Liu, H., Olshen, R.A., McDonald, K.M., Owens, D.K. Systematic review: A century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med 2006, 144(4): 270-80.
5. Inglesby, T.V., O'Toote, T., Henderson, D.A. et al. Anthrax as a biological weapon, 2002: Updated recommendations for management. JAMA 2002, 287(17): 2236-52.
6. Jernigan, J.A., Stephens, D.S., Ashfod, D.A. et al. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerg Infect Dis 2001, 7(6): 933-44.
7. Golden, H.B., Watson, L.E., Lal, H. et al. Anthrax toxin: Pathologic effects on the cardiovascular system. Front Biosci 2009, 14: 2335-57.
8. Choi, G., Zhang, X., Askins, J. et al. Selection of potent neutralizing human monoclonal antibodies to protective antigen of Bacillus anthracis. 43rd Intersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 14-17, Chicago) 2003, Abst G-280.
9. Okinaka, R.T., Cloud, K., Hampton, O. et al. Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J Bacteriol 1999, 181(20): 6509-15. (Pubitemid 29512963)
10. Pannifer, A.D., Wong, T.Y., Schwarzenbacher, R. et al. Crystal structure of the anthrax lethal factor. Nature 2001, 414(6860): 229-33. (Pubitemid 33051240)
11. Young, J.A., Collier, R.J. Anthrax toxin: Receptor binding, internalization, pore formation, and translocation. Annu Rev Biochem 2007, 76: 243-65.
12. Moayeri, M., Leppla, S.H. The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol 2004, 7(1): 19-24.
13. Friedlander, A.M., Little, S.F. Advances in the development of next-generation anthrax vaccines. Vaccine 2009, 27(Suppl. 4): D28-32.
14. Bradley, K.A., Mogridge, J., Mourez, M., Collier, R.J., Young, J.A. Identification of the cellular receptor for anthrax toxin. Nature 2001, 414(6860): 225-9.
15. Scobie, H.M., Rainey, G.J., Bradley, K.A., Young, J.A. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A 2003, 100(9): 5170-4.
16. Bradley, K.A., Young, J.A. Anthrax toxin receptor proteins. Biochem Pharmacol 2003, 65(3): 309-14.
17. Cho, Y., Gentile, L., Gill, J., Basu, S., Ma, Z., Ullrich, S. Characterization of raxibacumab, a potential therapy against Bacillus anthracis. 47th Intersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 17-20, Chicago) 2007, Abst F1-306.
18. Gorse, G.J., Keitel, W., Keyserling, H. et al. Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial. Vaccine 2006, 24(33-34): 5950-9.
19. Migone, T.S., Subramanian, G.M., Zhong, J. et al. Raxibacumab for the treatment of inhalational anthrax. New Engl J Med 2009, 361(2): 135-44.
20. Beebe, L., Babin, M., Barnewall, R., Zhong, J., Choi, G. Post-exposure therapeutic potential of PA mAb in an inhalation model of anthrax in New Zealand white rabbits (NZW). 2nd Annu ASM Biodefense Emerging Dis Res Meet (March 7-10. Baltimore) 2004, Abst 167 (G).
21. Beebe, L.E., Zhong, J., Clagett, M. et al. Protection against inhalation anthrax-induced lethality by a human monoclonal antibody to protective antigen in rabbits and cynomolgus monkeys. 43rd lntersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 14-17, Chicago) 2003, Abst B-331.
22. Cui, X., Li, Y., Li, X. et al. Protective antigen directed monoclonal antibody (Pa-mAb) administered 6 to 12 h after initiation of a 24 h lethal toxin infusion increases survival rates in a rat model of anthrax sepsis. 2nd Annu ASM Biodefense Emerging Dis Res Meet (March 7-10, Baltimore) 2004, Abst 55 (G).
23. Zmuda, J.F., Zhang, L., Sosnovtseva, S., Bukreyeva, N., Beebe, L., Hunt, R., Choi, G.H. Detection of host-derived neutralizing antibodies against anthrax protective antigen (PA) in PAmAb-treated monkeys surviving lethal spore challenge: Relationship to secondary exposure immunity. 2nd Annu ASM Biodefense Emerging Dis Res Meet (March 7-10, Baltimore) 2004, Abst 65 (H).
24. Kahn, D. Development and characterization of a scalable purification for ABthrax. 2nd Annu ASM Biodefense Emerging Dis Res Meet (March 7-10, Baltimore) 2004, Abst 169 (G).
25. Migone, T., Devataraja, M., Corey, A. et al. Efficacy of raxibacumab in the treatment of inhalational anthrax infection in rabbits and non-human primates. 48th Annu Intersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, D.C.) 2008, Abst B-1913.
26. Healey, L., Zimmerman, J., Farmer, F. et al. Safety and pharmacokinetics of raxibacumab: A novel agent for the treatment of inhalational anthrax. 48th Annu Intersci Conf Antimicrob Agents Chemother (ICAAC) Infect Dis Soc Am (IDSA) Annu Meet (Oct 25-28, Washington, D.C.) 2008, Abst B-1913.
27. Subramanian, M., Cronin, P., Poley, G. et al. ABthrax (PAmAb) - A novel, fully human monoclonal antibody against protective antigen of B. anthracis: Results from a phase 1 single dose-escalation study in healthy human subjects. 2nd Annu ASM Biodefense Emerging Dis Res Meet (March 7-10, Baltimore) 2004, Abst 158 (D).